Procurement of lateral flow cassettes for the rapid HIV nucleic acid diagnostic test

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

CDC OFFICE OF ACQUISITION SERVICES

Contract Value

Not provided

Codes & Classification
Solicitation Number

2026-Q-99143

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6550

Additional Details
Set Aside

NONE

Place of Performance

Atlanta, Georgia, UNITED STATES

SourceSAM
Documents1
The Centers for Disease Control and Prevention (CDC), through its Office of Acquisition Services, has issued a combined synopsis/solicitation for the procurement of lateral flow cassettes designed for rapid HIV nucleic acid diagnostic testing. This procurement, identified under solicitation number 75D301-26-Q-79168 (Procurement Identifier: 2026-Q-99143), seeks commercial products or services in accordance with the procedures outlined in FAR subpart 12.6. The notice serves as both the synopsis and the solicitation; therefore, interested vendors are invited to submit proposals directly in response to this announcement, as no separate written solicitation will be provided. The primary objective of this procurement is to acquire lateral flow cassettes that enable rapid, reliable detection of HIV nucleic acids, supporting the CDC’s ongoing efforts in public health surveillance, diagnosis, and intervention. The intended outcome is to enhance the agency’s capacity for timely and accurate HIV testing, which is critical for disease monitoring and prevention initiatives. Key requirements for this opportunity include the provision of commercial-grade lateral flow cassettes specifically engineered for rapid HIV nucleic acid testing. Vendors must ensure that their products meet the analytical and performance standards necessary for use in a laboratory setting, as classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing). The associated Product Service Code is 6550, which pertains to in vitro diagnostic substances, reagents, test kits, and sets. The place of performance for this contract is Atlanta, Georgia, United States. All deliverables are expected to be provided to this location, supporting the CDC’s operational needs within the region. This solicitation is not set aside for small business concerns; it is open to all qualified vendors regardless of business size. There are no special set-aside requirements or restrictions indicated in the notice. The procurement is classified as a commercial item acquisition, and all interested parties must comply with the terms and conditions outlined in the solicitation documentation. The contracting activity is managed by the CDC Office of Acquisition Services, a federal office within the Department of Health and Human Services. The primary point of contact for this procurement is Debra Baker ([email protected]), with Liubov Kriel ([email protected]) listed as the secondary contact for inquiries or clarifications. The solicitation was posted on July 29, 2026, and remains active. All proposals must be submitted by August 18, 2026, at 18:08. Additional details, including any attachments, can be accessed via the official SAM.gov opportunity listing at https://sam.gov/opp/d16b2ad53e0f498da8b14120778dbcbe/view. Contractors considering this opportunity should ensure their products align with the specified diagnostic application, meet the relevant regulatory and performance standards, and are capable of timely delivery to the designated location in Atlanta, Georgia. This procurement represents a critical component of the CDC’s public health mission and offers an opportunity for qualified suppliers to contribute to national HIV diagnostic efforts.